Neonatal screening in the future of children with spinal muscle atrophy

2021, Number 2

Rev Cubana Neurol Neurocir 2021; 11 (2)

Millán JM, Santana HEE

Language: Spanish
References: 4
Page: 1-4
PDF size: 127.26 Kb.

Text Extraction

No abstract.

REFERENCES

Zaldívar T, Montejo Y, Acevedo AM, Guerra R, Vargas J, Garofalo N, et al. Evidence of reduced frequency of spinal muscular atrophy type I in the Cuban population. Neurology. 2005;65(4):636-8. Doi: 10.1212/01.wnl.0000172860.41953.12
Viñas C, Martín I, Zaldívar T, Garófalo N, Zayas M, Guerra R, et al. Análisis genético molecular de pacientes con probable diagnóstico clínico de atrofia muscular espinal en Cuba. Revista Chilena de Pediatría. 2013;84(5):499-504. Doi: 10.4067/S0370-41062013000500003
Padilla CD, Krotoski D, Therrell BL Jr. Newborn screening progress in developing countries--overcoming internal barriers. Semin Perinatol. 2010 Apr;34(2):145-55. Doi: 10.1053/j.semperi.2009.12.007. PMID: 20207264.
Botler J, Camacho LA, da Cruz MM, George P. Neonatal screening – the challenge of an universal and effective coverage. Cien Saude Colet. 2010 Mar;15(2):493-508. Doi: 10.1590/S1413-81232010000200026. PMID: 20414617.